| 13913-004 | Gralise | gabapentin | Depomed, Inc. | NDA | Current |
| 13913-004 | Gralise | gabapentin | Assertio Therapeutics, Inc. | NDA | Current |
| 13913-004 | Gralise | gabapentin | Assertio Therapeutics, Inc. | NDA | Current |
| 13913-004 | Gralise | gabapentin | Assertio Therapeutics, Inc. | NDA | Current |
| 13913-004 | Gralise | gabapentin | Assertio Therapeutics, Inc. | NDA | Current |
| 13913-005 | Gralise | gabapentin | Assertio Therapeutics, Inc. | NDA | Current |
| 13913-005 | Gralise | gabapentin | Depomed, Inc. | NDA | Current |
| 13913-005 | Gralise | gabapentin | Assertio Therapeutics, Inc. | NDA | Current |
| 13913-005 | Gralise | gabapentin | Assertio Therapeutics, Inc. | NDA | Current |
| 13913-005 | Gralise | gabapentin | Assertio Therapeutics, Inc. | NDA | Current |
| 13913-006 | Gralise | gabapentin | Depomed, Inc. | NDA | Current |
| 13913-006 | Gralise | gabapentin | Assertio Therapeutics, Inc. | NDA | Current |
| 13913-006 | Gralise | gabapentin | Assertio Therapeutics, Inc. | NDA | Current |
| 50436-1262 | Gralise | gabapentin | Unit Dose Services | NDA | Current |
| 52427-803 | Gralise | gabapentin | Almatica Pharma LLC | NDA | Current |
| 52427-803 | Gralise | gabapentin | Almatica Pharma LLC | NDA | Current |
| 52427-803 | Gralise | gabapentin | Almatica Pharma LLC | NDA | Current |
| 52427-806 | Gralise | gabapentin | Almatica Pharma LLC | NDA | Current |
| 52427-806 | Gralise | gabapentin | Almatica Pharma LLC | NDA | Current |
| 52427-806 | Gralise | gabapentin | Almatica Pharma LLC | NDA | Current |
| 52427-815 | Gralise | gabapentin | Almatica Pharma LLC | NDA | Current |
| 52427-815 | Gralise | gabapentin | Almatica Pharma LLC | NDA | Current |
| 52427-815 | Gralise | gabapentin | Almatica Pharma LLC | NDA | Current |